The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Chemokines and cancer
Abstract
The chemokines and their receptors are a superfamily of small secreted molecules that control the migration of many cell types in the body. Several years ago it became clear that some chemokines and receptors regulate the migration of certain cells in the lymphoid system, and this raised the possibility that chemokines could also control the migration of tumor cells in the body. Breast cancer cells were found to express chemokine receptors in a nonrandom manner, and these observations pointed to several chemokine/receptor pairs that control tumor‐cell migration. The most important ligand/receptors pairs in these phenomena include CXCL12/CXCR4 and CCL21/CCR7. Since then, there has been intense interest in this area and many studies have been published, especially on CXCR4. These studies point to the following conclusions: (i) Tumors express chemokine receptors in a nonrandom manner. (ii) CXCR4 is the most widely expressed chemokine receptor in many different cancers. (iii) CCR7 is also expressed by many cancers, and is likely to mediate metastasis to the lymph nodes in selected cancers. (iv) The effects of CXCL12 on CXCR4‐bearing tumor cells likely include many other functions (growth, differentiation) besides migration. During normal development, the interaction CXCL12/CXCR4 is known to be involved in organogenesis. This process shares many characteristics with metastasis, and represents one of the key areas of future research. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Self-citationZlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Self-citationFunction of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function
Schaerli, P., Willimann, K., Lang, A. B., Lipp, M., Loetscher, P., & Moser, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1553 · Cited by 1,261
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
CCL27–CCR10 interactions regulate T cell–mediated skin inflammation
Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bünemann, E., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-157 · Cited by 807
Self-citationGerminal center dark and light zone organization is mediated by CXCR4 and CXCR5
Allen, C. D. C., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1100 · Cited by 802
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
Silencing of CXCR4 Blocks Breast Cancer Metastasis
Liang, Z., Yoon, Y., Votaw, J., Goodman, M. M., Williams, L., & Shim, H. (2005) · Cancer Research · doi:10.1158/0008-5472.967.65.3 · Cited by 402
Verge, G. M., Milligan, E. D., Maier, S. F., Watkins, L. R., Naeve, G. S., & Foster, A. C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03593.x · Cited by 386
Kim, J., Takeuchi, H., Lam, S. T., Turner, R. R., Wang, H.-J., Kuo, C., Foshag, L., Bilchik, A. J., & Hoon, D. S. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.078 · Cited by 378
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M.-T., & Hwang, S. T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1638 · Cited by 377
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
Murakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 347
Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Svensson, M., Marsal, J., Ericsson, A., Carramolino, L., Brodén, T., Márquez, G., & Agace, W. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15988 · Cited by 307
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.
Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., Inoue, H., & Mori, M. (2002) · PubMed · Cited by 298
Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)
Wang, W., Soto, H., Oldham, E. R., Buchanan, M. E., Homey, B., Catron, D., Jenkins, N., Copeland, N. G., Gilbert, D. J., Nguyen, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001461200 · Cited by 293
Self-citationExpression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma
Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., Napolitano, M., Franco, R., Botti, G., & Castello, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1887 · Cited by 280
Svensson, M., Marsal, J., Ericsson, A., Carramolino, L., Brodén, T., Márquez, G., & Agace, W. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215988 · Cited by 277
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer
Schimanski, C. C., Schwald, S., Simiantonaki, N., Jayasinghe, C., Gönner, U., Wilsberg, V., Junginger, T., Berger, M. R., Galle, P. R., & Moehler, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1195 · Cited by 257
The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity
Müller, G., Höpken, U. E., & Lipp, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00073.x · Cited by 251
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
Kaifi, J. T., Yekebas, E. F., Schurr, P., Obonyo, D., Wachowiak, R., Busch, P., Heinecke, A., Pantel, K., & Izbicki, J. R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji431 · Cited by 217
Nakano, H., & Gunn, M. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.361 · Cited by 210
Crazzolara, R., Kreczy, A., Mann, G., Heitger, A., Eibl, G., Fink, F., Möhle, R., & Meister, B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03164.x · Cited by 204
Ding, Y., Shimada, Y., Maeda, M., Kawabe, A., Kaganoi, J., Komoto, I., Hashimoto, Y., Miyake, M., Hashida, H., & Imamura, M. (2003) · PubMed · Cited by 199
Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis
Takanami, I. (2003) · International Journal of Cancer · doi:10.1002/ijc.11063 · Cited by 198
Cancer spread and micrometastasis development: Quantitative approaches for in vivo models
MacDonald, I. C., Groom, A. C., & Chambers, A. F. (2002) · BioEssays · doi:10.1002/bies.10156 · Cited by 181
Burger, J. A., & Kipps, T. J. (2002) · Leukemia & Lymphoma · doi:10.1080/10428190290011921 · Cited by 158
Laverdière, C., Hoang, B. H., Yang, R. R., Sowers, R. S., Qin, J., Meyers, P. A., Huvos, A. G., Healey, J. H., & Gorlick, R. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1089 · Cited by 157
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7
Günther, K., Leier, J., Henning, G., Dimmler, A. W., Weißbach, R., Hohenberger, W., & Förster, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21123 · Cited by 153
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
Trentin, L., Cabrelle, A., Facco, M., Carollo, D., Miorin, M., Tosoni, A., Pizzo, P., Binotto, G., Nicolardi, L., Zambello, R., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3103 · Cited by 150
Expression and function of chemokine receptors in human multiple myeloma
Möller, C., Strömberg, T., Juremalm, M., Nilsson, K., & Nilsson, G. P. (2003) · Leukemia · doi:10.1038/sj.leu.2402717 · Cited by 148
Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken, D., Scotton, C. J., Raju, S., Balkwill, F. R., & Wilson, J. L. (2002) · PubMed · Cited by 136
Sunnemark, D., Eltayeb, S., Nilsson, M., Wallström, E., Lassmann, H., Olsson, T. P., Berg, A., & Ericsson‐Dahlstrand, A. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-17 · Cited by 125
Höpken, U. E., Foss, H., Meyer, D., Hinz, M., Leder, K., Stein, H., & Lipp, M. (2002) · Blood · doi:10.1182/blood.v99.4.1109 · Cited by 120
Russell, H. V., Hicks, J. M., Okcu, M. F., & Nuchtern, J. G. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.06.019 · Cited by 111
Müller, A., Sonkoly, E., Eulert, C., Gerber, P. A., Kubitza, R., Schirlau, K., Franken‐Kunkel, P., Poremba, C., Snyderman, C. H., Klotz, L., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21514 · Cited by 104
Self-citationFunctional CCR9 Expression Is Associated with Small Intestinal Metastasis
Letsch, A., Keilholz, U., Schadendorf, D., Assfalg, G., Asemissen, A. M., Thiel, E., & Scheibenbogen, C. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22315.x · Cited by 98
Ghobrial, I. M., Bone, N. D., Stenson, M. J., Novak, A. J., Hedin, K. E., Kay, N. E., & Ansell, S. M. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.3.318 · Cited by 92
Expression of CXCR4 and Its Down-Regulation by IFN-γ in Head and Neck Squamous Cell Carcinoma
Katayama, A., Ogino, T., Bandoh, N., Nonaka, S., & Harabuchi, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1470 · Cited by 84
Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain
Westmoreland, S. V., Alvarez, X. A., deBakker, C. D., Aye, P. P., Wilson, M. L., Williams, K. C., & Lackner, A. A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00457-x · Cited by 83
CXCR4 mutations in WHIM syndrome: a misguided immune system?
Díaz, G. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00226.x · Cited by 80
Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma
Mourad, P. D., Farrell, L., Stamps, L. D., Chicoine, M. R., & Silbergeld, D. L. (2005) · Surgical Neurology · doi:10.1016/j.surneu.2004.08.062 · Cited by 69
Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma
Zeelenberg, I. S., Stalle, L. R.-V., & Roos, E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11330 · Cited by 62
Expression Analysis and Potential Functional Role of the CXCR4 Chemokine Receptor in Bladder Cancer
Eisenhardt, A., Frey, U. H., TACK, M., Rosskopf, D., Lümmen, G., Rubben, H., & Siffert, W. (2004) · European Urology · doi:10.1016/j.eururo.2004.10.001 · Cited by 49
Cited by
The CC chemokine CCL20 and its receptor CCR6
Schutyser, E., Struyf, S., & Van Damme, J. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00049-2 · Cited by 774
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
Role of chemokines in tumor growth
Raman, D., Baugher, P. J., Thu, Y. M., & Richmond, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.013 · Cited by 578
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
Metadata
- Authors
- Zlotnik, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-05-02
- Volume
- 119
- Issue
- 9
- Pages
- 2026-2029
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2072178451
- Cited by
- 421
- References
- 53
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.